img

Global Endometrial Cancer Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Endometrial Cancer Treatment Market Research Report 2024

According to MRAResearch’s new survey, global Endometrial Cancer Treatment market is projected to reach US$ 28750 million in 2033, increasing from US$ 21570 million in 2022, with the CAGR of 4.1% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Endometrial Cancer Treatment market research.
Key companies engaged in the Endometrial Cancer Treatment industry include Ariad, Abbott, BD, GlaxoSmithKline, Merck, Novartis, Sanofi, Siemens and Roche, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Endometrial Cancer Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Endometrial Cancer Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Endometrial Cancer Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Ariad
Abbott
BD
GlaxoSmithKline
Merck
Novartis
Sanofi
Siemens
Roche
Segment by Type
Chemotherapy
Surgical

Segment by Application


Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Endometrial Cancer Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endometrial Cancer Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Chemotherapy
1.2.3 Surgical
1.3 Market by Application
1.3.1 Global Endometrial Cancer Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endometrial Cancer Treatment Market Perspective (2018-2033)
2.2 Endometrial Cancer Treatment Growth Trends by Region
2.2.1 Global Endometrial Cancer Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Endometrial Cancer Treatment Historic Market Size by Region (2018-2023)
2.2.3 Endometrial Cancer Treatment Forecasted Market Size by Region (2024-2033)
2.3 Endometrial Cancer Treatment Market Dynamics
2.3.1 Endometrial Cancer Treatment Industry Trends
2.3.2 Endometrial Cancer Treatment Market Drivers
2.3.3 Endometrial Cancer Treatment Market Challenges
2.3.4 Endometrial Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endometrial Cancer Treatment Players by Revenue
3.1.1 Global Top Endometrial Cancer Treatment Players by Revenue (2018-2023)
3.1.2 Global Endometrial Cancer Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Endometrial Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Endometrial Cancer Treatment Revenue
3.4 Global Endometrial Cancer Treatment Market Concentration Ratio
3.4.1 Global Endometrial Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endometrial Cancer Treatment Revenue in 2022
3.5 Endometrial Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Endometrial Cancer Treatment Product Solution and Service
3.7 Date of Enter into Endometrial Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Endometrial Cancer Treatment Breakdown Data by Type
4.1 Global Endometrial Cancer Treatment Historic Market Size by Type (2018-2023)
4.2 Global Endometrial Cancer Treatment Forecasted Market Size by Type (2024-2033)
5 Endometrial Cancer Treatment Breakdown Data by Application
5.1 Global Endometrial Cancer Treatment Historic Market Size by Application (2018-2023)
5.2 Global Endometrial Cancer Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Endometrial Cancer Treatment Market Size (2018-2033)
6.2 North America Endometrial Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Endometrial Cancer Treatment Market Size by Country (2018-2023)
6.4 North America Endometrial Cancer Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Endometrial Cancer Treatment Market Size (2018-2033)
7.2 Europe Endometrial Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Endometrial Cancer Treatment Market Size by Country (2018-2023)
7.4 Europe Endometrial Cancer Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endometrial Cancer Treatment Market Size (2018-2033)
8.2 Asia-Pacific Endometrial Cancer Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Endometrial Cancer Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Endometrial Cancer Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Endometrial Cancer Treatment Market Size (2018-2033)
9.2 Latin America Endometrial Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Endometrial Cancer Treatment Market Size by Country (2018-2023)
9.4 Latin America Endometrial Cancer Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endometrial Cancer Treatment Market Size (2018-2033)
10.2 Middle East & Africa Endometrial Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Endometrial Cancer Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Endometrial Cancer Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ariad
11.1.1 Ariad Company Detail
11.1.2 Ariad Business Overview
11.1.3 Ariad Endometrial Cancer Treatment Introduction
11.1.4 Ariad Revenue in Endometrial Cancer Treatment Business (2018-2023)
11.1.5 Ariad Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Endometrial Cancer Treatment Introduction
11.2.4 Abbott Revenue in Endometrial Cancer Treatment Business (2018-2023)
11.2.5 Abbott Recent Development
11.3 BD
11.3.1 BD Company Detail
11.3.2 BD Business Overview
11.3.3 BD Endometrial Cancer Treatment Introduction
11.3.4 BD Revenue in Endometrial Cancer Treatment Business (2018-2023)
11.3.5 BD Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Endometrial Cancer Treatment Introduction
11.4.4 GlaxoSmithKline Revenue in Endometrial Cancer Treatment Business (2018-2023)
11.4.5 GlaxoSmithKline Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Endometrial Cancer Treatment Introduction
11.5.4 Merck Revenue in Endometrial Cancer Treatment Business (2018-2023)
11.5.5 Merck Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Endometrial Cancer Treatment Introduction
11.6.4 Novartis Revenue in Endometrial Cancer Treatment Business (2018-2023)
11.6.5 Novartis Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Endometrial Cancer Treatment Introduction
11.7.4 Sanofi Revenue in Endometrial Cancer Treatment Business (2018-2023)
11.7.5 Sanofi Recent Development
11.8 Siemens
11.8.1 Siemens Company Detail
11.8.2 Siemens Business Overview
11.8.3 Siemens Endometrial Cancer Treatment Introduction
11.8.4 Siemens Revenue in Endometrial Cancer Treatment Business (2018-2023)
11.8.5 Siemens Recent Development
11.9 Roche
11.9.1 Roche Company Detail
11.9.2 Roche Business Overview
11.9.3 Roche Endometrial Cancer Treatment Introduction
11.9.4 Roche Revenue in Endometrial Cancer Treatment Business (2018-2023)
11.9.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Endometrial Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Surgical
Table 4. Global Endometrial Cancer Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Endometrial Cancer Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Endometrial Cancer Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Endometrial Cancer Treatment Market Share by Region (2018-2023)
Table 8. Global Endometrial Cancer Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Endometrial Cancer Treatment Market Share by Region (2024-2033)
Table 10. Endometrial Cancer Treatment Market Trends
Table 11. Endometrial Cancer Treatment Market Drivers
Table 12. Endometrial Cancer Treatment Market Challenges
Table 13. Endometrial Cancer Treatment Market Restraints
Table 14. Global Endometrial Cancer Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Endometrial Cancer Treatment Market Share by Players (2018-2023)
Table 16. Global Top Endometrial Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometrial Cancer Treatment as of 2022)
Table 17. Ranking of Global Top Endometrial Cancer Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Endometrial Cancer Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Endometrial Cancer Treatment Product Solution and Service
Table 21. Date of Enter into Endometrial Cancer Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Endometrial Cancer Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Endometrial Cancer Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Endometrial Cancer Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Endometrial Cancer Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Endometrial Cancer Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Endometrial Cancer Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Endometrial Cancer Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Endometrial Cancer Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America Endometrial Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Endometrial Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Endometrial Cancer Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Endometrial Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Endometrial Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Endometrial Cancer Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Endometrial Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Endometrial Cancer Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Endometrial Cancer Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Endometrial Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Endometrial Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Endometrial Cancer Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Endometrial Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Endometrial Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Endometrial Cancer Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Ariad Company Detail
Table 47. Ariad Business Overview
Table 48. Ariad Endometrial Cancer Treatment Product
Table 49. Ariad Revenue in Endometrial Cancer Treatment Business (2018-2023) & (US$ Million)
Table 50. Ariad Recent Development
Table 51. Abbott Company Detail
Table 52. Abbott Business Overview
Table 53. Abbott Endometrial Cancer Treatment Product
Table 54. Abbott Revenue in Endometrial Cancer Treatment Business (2018-2023) & (US$ Million)
Table 55. Abbott Recent Development
Table 56. BD Company Detail
Table 57. BD Business Overview
Table 58. BD Endometrial Cancer Treatment Product
Table 59. BD Revenue in Endometrial Cancer Treatment Business (2018-2023) & (US$ Million)
Table 60. BD Recent Development
Table 61. GlaxoSmithKline Company Detail
Table 62. GlaxoSmithKline Business Overview
Table 63. GlaxoSmithKline Endometrial Cancer Treatment Product
Table 64. GlaxoSmithKline Revenue in Endometrial Cancer Treatment Business (2018-2023) & (US$ Million)
Table 65. GlaxoSmithKline Recent Development
Table 66. Merck Company Detail
Table 67. Merck Business Overview
Table 68. Merck Endometrial Cancer Treatment Product
Table 69. Merck Revenue in Endometrial Cancer Treatment Business (2018-2023) & (US$ Million)
Table 70. Merck Recent Development
Table 71. Novartis Company Detail
Table 72. Novartis Business Overview
Table 73. Novartis Endometrial Cancer Treatment Product
Table 74. Novartis Revenue in Endometrial Cancer Treatment Business (2018-2023) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Sanofi Company Detail
Table 77. Sanofi Business Overview
Table 78. Sanofi Endometrial Cancer Treatment Product
Table 79. Sanofi Revenue in Endometrial Cancer Treatment Business (2018-2023) & (US$ Million)
Table 80. Sanofi Recent Development
Table 81. Siemens Company Detail
Table 82. Siemens Business Overview
Table 83. Siemens Endometrial Cancer Treatment Product
Table 84. Siemens Revenue in Endometrial Cancer Treatment Business (2018-2023) & (US$ Million)
Table 85. Siemens Recent Development
Table 86. Roche Company Detail
Table 87. Roche Business Overview
Table 88. Roche Endometrial Cancer Treatment Product
Table 89. Roche Revenue in Endometrial Cancer Treatment Business (2018-2023) & (US$ Million)
Table 90. Roche Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endometrial Cancer Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Endometrial Cancer Treatment Market Share by Type: 2022 VS 2033
Figure 3. Chemotherapy Features
Figure 4. Surgical Features
Figure 5. Global Endometrial Cancer Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Endometrial Cancer Treatment Market Share by Application: 2022 VS 2033
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Endometrial Cancer Treatment Report Years Considered
Figure 10. Global Endometrial Cancer Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Endometrial Cancer Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Endometrial Cancer Treatment Market Share by Region: 2022 VS 2033
Figure 13. Global Endometrial Cancer Treatment Market Share by Players in 2022
Figure 14. Global Top Endometrial Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometrial Cancer Treatment as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Endometrial Cancer Treatment Revenue in 2022
Figure 16. North America Endometrial Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Endometrial Cancer Treatment Market Share by Country (2018-2033)
Figure 18. United States Endometrial Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada Endometrial Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe Endometrial Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Endometrial Cancer Treatment Market Share by Country (2018-2033)
Figure 22. Germany Endometrial Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France Endometrial Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. Endometrial Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy Endometrial Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia Endometrial Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries Endometrial Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific Endometrial Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Endometrial Cancer Treatment Market Share by Region (2018-2033)
Figure 30. China Endometrial Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan Endometrial Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea Endometrial Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia Endometrial Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India Endometrial Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia Endometrial Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America Endometrial Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Endometrial Cancer Treatment Market Share by Country (2018-2033)
Figure 38. Mexico Endometrial Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil Endometrial Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa Endometrial Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Endometrial Cancer Treatment Market Share by Country (2018-2033)
Figure 42. Turkey Endometrial Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia Endometrial Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Ariad Revenue Growth Rate in Endometrial Cancer Treatment Business (2018-2023)
Figure 45. Abbott Revenue Growth Rate in Endometrial Cancer Treatment Business (2018-2023)
Figure 46. BD Revenue Growth Rate in Endometrial Cancer Treatment Business (2018-2023)
Figure 47. GlaxoSmithKline Revenue Growth Rate in Endometrial Cancer Treatment Business (2018-2023)
Figure 48. Merck Revenue Growth Rate in Endometrial Cancer Treatment Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Endometrial Cancer Treatment Business (2018-2023)
Figure 50. Sanofi Revenue Growth Rate in Endometrial Cancer Treatment Business (2018-2023)
Figure 51. Siemens Revenue Growth Rate in Endometrial Cancer Treatment Business (2018-2023)
Figure 52. Roche Revenue Growth Rate in Endometrial Cancer Treatment Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed